We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-25.09%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.79B
AUM Growth
-$1.17B
Cap. Flow
-$394M
Cap. Flow %
-22.03%
Top 10 Hldgs %
23.27%
Holding
291
New
26
Increased
34
Reduced
190
Closed
30

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$13.4M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$12M
3
RDWR icon
Radware
RDWR
+$11.2M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$11M
5
PRGS icon
Progress Software
PRGS
+$10.7M

Top Sells

Rank Stock Value
1
PFGC icon
Performance Food Group
PFGC
+$19.8M
2
EBS icon
Emergent Biosolutions
EBS
+$19.3M
3
IMAX icon
IMAX
IMAX
+$16.9M
4
CY
Cypress Semiconductor
CY
+$16.8M
5
POOL icon
Pool Corp
POOL
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.39%
2 Technology 21.19%
3 Industrials 18.35%
4 Consumer Discretionary 10.8%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AX icon
26
Axos Financial
AX
$5.68B
$20.7M 1.16%
1,140,691
-38,535
-3% -$969K
PBH icon
27
Prestige Consumer Healthcare
PBH
$2.6B
$20M 1.12%
544,806
-18,009
-3% -$699K
IAA
28
DELISTED
IAA, Inc. Common Stock
IAA
$18.6M 1.04%
622,409
+185,135
+42% +$8M
BSTC
29
DELISTED
BioSpecifics Technologies Corp.
BSTC
$18.2M 1.02%
321,994
-26,468
-8% -$1.51M
AERI
30
DELISTED
Aerie Pharmaceuticals
AERI
$17.4M 0.97%
1,286,131
+173,404
+16% +$3.29M
SUPN icon
31
Supernus Pharmaceuticals
SUPN
$2.77B
$17M 0.95%
947,555
-14,418
-1% -$303K
COLL icon
32
Collegium Pharmaceutical
COLL
$956M
$16.9M 0.94%
1,033,821
-22,565
-2% -$466K
EEFT icon
33
Euronet Worldwide
EEFT
$2.7B
$16.8M 0.94%
195,465
-5,291
-3% -$701K
WIFI
34
DELISTED
Boingo Wireless, Inc.
WIFI
$16.5M 0.92%
1,552,359
-40,169
-3% -$466K
RVNC
35
DELISTED
Revance Therapeutics, Inc.
RVNC
$15.2M 0.85%
1,030,281
-35,847
-3% -$741K
ECHO
36
DELISTED
Echo Global Logistics, Inc.
ECHO
$14.9M 0.83%
870,728
-125,014
-13% -$2.44M
CSOD
37
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$14.9M 0.83%
468,355
+174,480
+59% +$8.51M
RETA
38
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14.6M 0.81%
100,926
-3,423
-3% -$661K
IMMU
39
DELISTED
Immunomedics Inc
IMMU
$14.3M 0.8%
1,061,014
+9,543
+0.9% +$161K
ON icon
40
ON Semiconductor
ON
$31.6B
$14.3M 0.8%
1,148,165
-238,122
-17% -$4.66M
AIMT
41
DELISTED
Aimmune Therapeutics
AIMT
$14.2M 0.79%
982,484
+257,053
+35% +$6.57M
CMPR icon
42
Cimpress
CMPR
$2.31B
$13.6M 0.76%
254,870
-30,654
-11% -$3.11M
IOVA icon
43
Iovance Biotherapeutics
IOVA
$2.87B
$13.5M 0.76%
+452,342
New +$12M
OZK icon
44
Bank OZK
OZK
$5.61B
$12.9M 0.72%
772,646
-8,749
-1% -$225K
TFX icon
45
Teleflex
TFX
$5.98B
$12.1M 0.68%
41,443
-1,647
-4% -$575K
WLDN icon
46
Willdan Group
WLDN
$1.3B
$12M 0.67%
562,777
-61,104
-10% -$1.88M
KPTI icon
47
Karyopharm Therapeutics
KPTI
$48M
$11.5M 0.64%
+39,783
New +$11M
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
$11.4M 0.63%
222,255
-7,597
-3% -$509K
AKBA icon
49
Akebia Therapeutics
AKBA
$252M
$10.7M 0.6%
1,407,164
+8,543
+0.6% +$66.5K
NKTR icon
50
Nektar Therapeutics
NKTR
$2.58B
$10.4M 0.58%
38,902
-893
-2% -$276K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Rice Hall James & Associates held 291 positions worth $1.79B, down 39% from $2.96B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $394M in Q1 2020, closing 30 positions and reducing 190 holdings. Its most notable exit was Performance Food Group, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Zogenix, Inc. worth $9.13M.

  • Rice Hall James & Associates's largest Q1 2020 buy was Zogenix, Inc.: 369,261 shares worth $9.13M.
  • Rice Hall James & Associates added most to Radware in Q1 2020, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q1 2020 reduction was Emergent Biosolutions, cutting an estimated $19.3M.
  • Rice Hall James & Associates fully exited Performance Food Group in Q1 2020, selling an estimated $19.8M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.79B portfolio in Q1 2020.
  • Rice Hall James & Associates opened 26 new positions and closed 30 in Q1 2020.
  • Rice Hall James & Associates's portfolio value fell 39% quarter-over-quarter to $1.79B.

Based on Rice Hall James & Associates's 13F filing for Q1 2020, filed 15 May 2020.